Literature DB >> 18793029

Funding a clinical trial: the perspective of a medicines funder.

Peter Alsop1, Scott Metcalfe, Jackie Evans.   

Abstract

Mesh：

Year:  2008        PMID： 18793029     DOI： 10.2165/00019053-200826100-00002

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  20 in total

Review 1.  Towards the optimal use of inhaled corticosteroid therapy in adult asthma.

Authors:  P Shirtcliffe; S Holt; J Crane; R Beasley
Journal:  N Z Med J       Date:  2001-06-08

2.  Ethnicity, equity, and quality: lessons from New Zealand.

Authors:  K M McPherson; M Harwood; H K McNaughton
Journal:  BMJ       Date:  2003-08-23

3.  Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.

Authors:  C Courtney; D Farrell; R Gray; R Hills; L Lynch; E Sellwood; S Edwards; W Hardyman; J Raftery; P Crome; C Lendon; H Shaw; P Bentham
Journal:  Lancet       Date:  2004-06-26       Impact factor: 79.321

Review 4.  Users' guide to detecting misleading claims in clinical research reports.

Authors:  Victor M Montori; Roman Jaeschke; Holger J Schünemann; Mohit Bhandari; Jan L Brozek; P J Devereaux; Gordon H Guyatt
Journal:  BMJ       Date:  2004-11-06

5.  The price of sight--ranibizumab, bevacizumab, and the treatment of macular degeneration.

Authors:  Robert Steinbrook
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

6.  A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth.

Authors:  Sébastien Bonnet; Stephen L Archer; Joan Allalunis-Turner; Alois Haromy; Christian Beaulieu; Richard Thompson; Christopher T Lee; Gary D Lopaschuk; Lakshmi Puttagunta; Sandra Bonnet; Gwyneth Harry; Kyoko Hashimoto; Christopher J Porter; Miguel A Andrade; Bernard Thebaud; Evangelos D Michelakis
Journal:  Cancer Cell       Date:  2007-01       Impact factor: 31.743

7.  2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.

Authors:  Ian Smith; Marion Procter; Richard D Gelber; Sébastien Guillaume; Andrea Feyereislova; Mitch Dowsett; Aron Goldhirsch; Michael Untch; Gabriella Mariani; Jose Baselga; Manfred Kaufmann; David Cameron; Richard Bell; Jonas Bergh; Robert Coleman; Andrew Wardley; Nadia Harbeck; Roberto I Lopez; Peter Mallmann; Karen Gelmon; Nicholas Wilcken; Erik Wist; Pedro Sánchez Rovira; Martine J Piccart-Gebhart
Journal:  Lancet       Date:  2007-01-06       Impact factor: 79.321

8.  The value meal: how to save $1,700 per month or more on lapatinib.

Authors:  Mark J Ratain; Ezra E Cohen
Journal:  J Clin Oncol       Date:  2007-07-16       Impact factor: 44.544

9.  Trastuzumab in early-stage breast cancer: the question of treatment timing.

Authors:  Steven Simoens
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

10.  Leaping to conclusions.

Authors:  Margaret McCartney
Journal:  BMJ       Date:  2008-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.